Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbvie CDR (Cad Hedged) (ABBV.TO)

Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 512,647,843
  • Shares Outstanding, K 16,712,880
  • Annual Sales, $ 61,160 M
  • Annual Income, $ 4,226 M
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.61
  • Price/Sales 5.78
  • Price/Cash Flow 18.56
  • Price/Book N/A
  • Price/Earnings ttm 84.07
  • Earnings Per Share ttm 0.25
  • Most Recent Earnings $0.11 on 02/04/26
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) 0.97 (3.22%)
  • Most Recent Dividend 0.242 on 04/15/26
  • Sector Medical
  • INDUSTRY GROUPING:

    TSX Drug Manufacturers - Major

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.36 +3.39%
on 03/24/26
33.34 -12.06%
on 03/04/26
-3.45 (-10.53%)
since 03/02/26
3-Month
28.36 +3.39%
on 03/24/26
33.34 -12.06%
on 03/04/26
-2.97 (-9.20%)
since 01/02/26
52-Week
23.67 +23.87%
on 04/09/25
34.68 -15.46%
on 10/01/25
-0.10 (-0.34%)
since 04/02/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox....

See More

Key Turning Points

3rd Resistance Point 30.98
2nd Resistance Point 30.60
1st Resistance Point 29.96
Last Price 29.32
1st Support Level 28.94
2nd Support Level 28.56
3rd Support Level 27.92

See More

52-Week High 34.68
Fibonacci 61.8% 30.47
Last Price 29.32
Fibonacci 50% 29.17
Fibonacci 38.2% 27.88
52-Week Low 23.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.